aluates Reports

$ 0.0

Automative

Global Mesalazine Market Research Report 2026

Published Date: 2026-02-27

Report Code: QYRE-Auto-26U8899

BUY CHAPTERS

Global Mesalazine Market Research Report 2026

Code: QYRE-Auto-26U8899

Report

2026-02-27

Pages:126

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PharmaZell GmbH

Syntese A/S

Chemi SPA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Cambrex Corporation

Mesalazine Market Size

The global Mesalazine market was valued at US$ 193 million in 2025 and is anticipated to reach US$ 256 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Mesalazine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mesalazine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

In 2024, global Mesalazine sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

This report delivers a comprehensive overview of the global Mesalazine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mesalazine. The Mesalazine market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Mesalazine market comprehensively. Regional market sizes by Purity, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Mesalazine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Purity, by Application, and by region.

Market Segmentation

Scope of Mesalazine Market Report

Report Metric	Details
Report Name	Mesalazine Market
Accounted market size in 2025	US$ 193 million
Forecasted market size in 2032	US$ 256 million
CAGR	4.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Purity	Purity ≥ 97% Purity ≥ 98% Purity ≥ 99%
by Application	Tablets Capsules Granule Suppository Enema Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Purity, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mesalazine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mesalazine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Purity, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Mesalazine Market growing?

Ans: The Mesalazine Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Mesalazine Market size in 2032?

Ans: The Mesalazine Market size in 2032 will be US$ 256 million.

What is the market share of major companies in Mesalazine Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalazine Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Who are the main players in the Mesalazine Market report?

Ans: The main players in the Mesalazine Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu)

What are the Application segmentation covered in the Mesalazine Market report?

Ans: The Applications covered in the Mesalazine Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

1 Mesalazine Market Overview

1.1 Product Definition

1.2 Mesalazine by Purity

1.2.1 Global Mesalazine Market Value by Purity: 2025 vs 2032

1.2.2 Purity ≥ 97%

1.2.3 Purity ≥ 98%

1.2.4 Purity ≥ 99%

1.3 Mesalazine by Application

1.3.1 Global Mesalazine Market Value by Application: 2025 vs 2032

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Granule

1.3.5 Suppository

1.3.6 Enema

1.3.7 Others

1.4 Global Mesalazine Market Size Estimates and Forecasts

1.4.1 Global Mesalazine Revenue 2021–2032

1.4.2 Global Mesalazine Sales 2021–2032

1.4.3 Global Mesalazine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Mesalazine Market Competition by Manufacturers

2.1 Global Mesalazine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Mesalazine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Mesalazine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Mesalazine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Mesalazine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Mesalazine, Product Types and Applications

2.7 Global Key Manufacturers of Mesalazine, Date of Entry into the Industry

2.8 Global Mesalazine Market Competitive Situation and Trends

2.8.1 Global Mesalazine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Mesalazine Players Market Share by Revenue

2.8.3 Global Mesalazine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Mesalazine Market Scenario by Region

3.1 Global Mesalazine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Mesalazine Sales by Region: 2021–2032

3.2.1 Global Mesalazine Sales by Region: 2021–2026

3.2.2 Global Mesalazine Sales by Region: 2027–2032

3.3 Global Mesalazine Revenue by Region: 2021–2032

3.3.1 Global Mesalazine Revenue by Region: 2021–2026

3.3.2 Global Mesalazine Revenue by Region: 2027–2032

3.4 North America Mesalazine Market Facts & Figures by Country

3.4.1 North America Mesalazine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Mesalazine Sales by Country (2021–2032)

3.4.3 North America Mesalazine Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Mesalazine Market Facts & Figures by Country

3.5.1 Europe Mesalazine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Mesalazine Sales by Country (2021–2032)

3.5.3 Europe Mesalazine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Mesalazine Market Facts & Figures by Region

3.6.1 Asia Pacific Mesalazine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Mesalazine Sales by Region (2021–2032)

3.6.3 Asia Pacific Mesalazine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Mesalazine Market Facts & Figures by Country

3.7.1 Latin America Mesalazine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Mesalazine Sales by Country (2021–2032)

3.7.3 Latin America Mesalazine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Mesalazine Market Facts & Figures by Country

3.8.1 Middle East and Africa Mesalazine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Mesalazine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Mesalazine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Purity

4.1 Global Mesalazine Sales by Purity (2021–2032)

4.1.1 Global Mesalazine Sales by Purity (2021–2026)

4.1.2 Global Mesalazine Sales by Purity (2027–2032)

4.1.3 Global Mesalazine Sales Market Share by Purity (2021–2032)

4.2 Global Mesalazine Revenue by Purity (2021–2032)

4.2.1 Global Mesalazine Revenue by Purity (2021–2026)

4.2.2 Global Mesalazine Revenue by Purity (2027–2032)

4.2.3 Global Mesalazine Revenue Market Share by Purity (2021–2032)

4.3 Global Mesalazine Price by Purity (2021–2032)

5 Segment by Application

5.1 Global Mesalazine Sales by Application (2021–2032)

5.1.1 Global Mesalazine Sales by Application (2021–2026)

5.1.2 Global Mesalazine Sales by Application (2027–2032)

5.1.3 Global Mesalazine Sales Market Share by Application (2021–2032)

5.2 Global Mesalazine Revenue by Application (2021–2032)

5.2.1 Global Mesalazine Revenue by Application (2021–2026)

5.2.2 Global Mesalazine Revenue by Application (2027–2032)

5.2.3 Global Mesalazine Revenue Market Share by Application (2021–2032)

5.3 Global Mesalazine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 PharmaZell

6.1.1 PharmaZell Company Information

6.1.2 PharmaZell Description and Business Overview

6.1.3 PharmaZell Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 PharmaZell Mesalazine Product Portfolio

6.1.5 PharmaZell Recent Developments/Updates

6.2 Syntese A/S

6.2.1 Syntese A/S Company Information

6.2.2 Syntese A/S Description and Business Overview

6.2.3 Syntese A/S Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Syntese A/S Mesalazine Product Portfolio

6.2.5 Syntese A/S Recent Developments/Updates

6.3 Cambrex Corporation

6.3.1 Cambrex Corporation Company Information

6.3.2 Cambrex Corporation Description and Business Overview

6.3.3 Cambrex Corporation Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Cambrex Corporation Mesalazine Product Portfolio

6.3.5 Cambrex Corporation Recent Developments/Updates

6.4 Divis Laboratories

6.4.1 Divis Laboratories Company Information

6.4.2 Divis Laboratories Description and Business Overview

6.4.3 Divis Laboratories Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Divis Laboratories Mesalazine Product Portfolio

6.4.5 Divis Laboratories Recent Developments/Updates

6.5 Chemi SpA

6.5.1 Chemi SpA Company Information

6.5.2 Chemi SpA Description and Business Overview

6.5.3 Chemi SpA Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Chemi SpA Mesalazine Product Portfolio

6.5.5 Chemi SpA Recent Developments/Updates

6.6 Ipca Laboratories

6.6.1 Ipca Laboratories Company Information

6.6.2 Ipca Laboratories Description and Business Overview

6.6.3 Ipca Laboratories Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Ipca Laboratories Mesalazine Product Portfolio

6.6.5 Ipca Laboratories Recent Developments/Updates

6.7 Hangzhou Brother

6.7.1 Hangzhou Brother Company Information

6.7.2 Hangzhou Brother Description and Business Overview

6.7.3 Hangzhou Brother Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Hangzhou Brother Mesalazine Product Portfolio

6.7.5 Hangzhou Brother Recent Developments/Updates

6.8 Lianyungang Fengheng Biopharm

6.8.1 Lianyungang Fengheng Biopharm Company Information

6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview

6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio

6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates

6.9 Lasa Loboratory

6.9.1 Lasa Loboratory Company Information

6.9.2 Lasa Loboratory Description and Business Overview

6.9.3 Lasa Loboratory Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Lasa Loboratory Mesalazine Product Portfolio

6.9.5 Lasa Loboratory Recent Developments/Updates

6.10 Corden Pharma Bergamo

6.10.1 Corden Pharma Bergamo Company Information

6.10.2 Corden Pharma Bergamo Description and Business Overview

6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio

6.10.5 Corden Pharma Bergamo Recent Developments/Updates

6.11 Erregierre SpA

6.11.1 Erregierre SpA Company Information

6.11.2 Erregierre SpA Description and Business Overview

6.11.3 Erregierre SpA Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Erregierre SpA Mesalazine Product Portfolio

6.11.5 Erregierre SpA Recent Developments/Updates

6.12 CTX Lifescience

6.12.1 CTX Lifescience Company Information

6.12.2 CTX Lifescience Description and Business Overview

6.12.3 CTX Lifescience Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 CTX Lifescience Mesalazine Product Portfolio

6.12.5 CTX Lifescience Recent Developments/Updates

6.13 Ishita Active Pharma Ingredients

6.13.1 Ishita Active Pharma Ingredients Company Information

6.13.2 Ishita Active Pharma Ingredients Description and Business Overview

6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio

6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates

6.14 YC Biotech (Jiangsu)

6.14.1 YC Biotech (Jiangsu) Company Information

6.14.2 YC Biotech (Jiangsu) Description and Business Overview

6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio

6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Mesalazine Industry Chain Analysis

7.2 Mesalazine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Mesalazine Production Mode & Process Analysis

7.4 Mesalazine Sales and Marketing

7.4.1 Mesalazine Sales Channels

7.4.2 Mesalazine Distributors

7.5 Mesalazine Customer Analysis

8 Mesalazine Market Dynamics

8.1 Mesalazine Industry Trends

8.2 Mesalazine Market Drivers

8.3 Mesalazine Market Challenges

8.4 Mesalazine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

PharmaZell GmbH

Syntese A/S

Chemi SPA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Cambrex Corporation

List of Tables

Table 1. Global Mesalazine Market Value by Purity (US$ Million), 2025 vs 2032

Table 2. Global Mesalazine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Mesalazine Market Competitive Situation by Manufacturers in 2025

Table 4. Global Mesalazine Sales (Tons) of Key Manufacturers (2021–2026)

Table 5. Global Mesalazine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Mesalazine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Mesalazine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Mesalazine Average Price (US$/kg) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Mesalazine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Mesalazine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Mesalazine, Product Types and Applications

Table 12. Global Key Manufacturers of Mesalazine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Mesalazine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mesalazine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Mesalazine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Mesalazine Sales by Region (Tons), 2021–2026

Table 18. Global Mesalazine Sales Market Share by Region (2021–2026)

Table 19. Global Mesalazine Sales by Region (Tons), 2027–2032

Table 20. Global Mesalazine Sales Market Share by Region (2027–2032)

Table 21. Global Mesalazine Revenue by Region (US$ Million), 2021–2026

Table 22. Global Mesalazine Revenue Market Share by Region (2021–2026)

Table 23. Global Mesalazine Revenue by Region (US$ Million), 2027–2032

Table 24. Global Mesalazine Revenue Market Share by Region (2027–2032)

Table 25. North America Mesalazine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Mesalazine Sales by Country (Tons), 2021–2026

Table 27. North America Mesalazine Sales by Country (Tons), 2027–2032

Table 28. North America Mesalazine Revenue by Country (US$ Million), 2021–2026

Table 29. North America Mesalazine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Mesalazine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Mesalazine Sales by Country (Tons), 2021–2026

Table 32. Europe Mesalazine Sales by Country (Tons), 2027–2032

Table 33. Europe Mesalazine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Mesalazine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Mesalazine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Mesalazine Sales by Region (Tons), 2021–2026

Table 37. Asia Pacific Mesalazine Sales by Region (Tons), 2027–2032

Table 38. Asia Pacific Mesalazine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Mesalazine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Mesalazine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Mesalazine Sales by Country (Tons), 2021–2026

Table 42. Latin America Mesalazine Sales by Country (Tons), 2027–2032

Table 43. Latin America Mesalazine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Mesalazine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Mesalazine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Mesalazine Sales by Country (Tons), 2021–2026

Table 47. Middle East and Africa Mesalazine Sales by Country (Tons), 2027–2032

Table 48. Middle East and Africa Mesalazine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Mesalazine Revenue by Country (US$ Million), 2027–2032

Table 50. Global Mesalazine Sales (Tons) by Purity (2021–2026)

Table 51. Global Mesalazine Sales (Tons) by Purity (2027–2032)

Table 52. Global Mesalazine Sales Market Share by Purity (2021–2026)

Table 53. Global Mesalazine Sales Market Share by Purity (2027–2032)

Table 54. Global Mesalazine Revenue (US$ Million) by Purity (2021–2026)

Table 55. Global Mesalazine Revenue (US$ Million) by Purity (2027–2032)

Table 56. Global Mesalazine Revenue Market Share by Purity (2021–2026)

Table 57. Global Mesalazine Revenue Market Share by Purity (2027–2032)

Table 58. Global Mesalazine Price (US$/kg) by Purity (2021–2026)

Table 59. Global Mesalazine Price (US$/kg) by Purity (2027–2032)

Table 60. Global Mesalazine Sales (Tons) by Application (2021–2026)

Table 61. Global Mesalazine Sales (Tons) by Application (2027–2032)

Table 62. Global Mesalazine Sales Market Share by Application (2021–2026)

Table 63. Global Mesalazine Sales Market Share by Application (2027–2032)

Table 64. Global Mesalazine Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Mesalazine Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Mesalazine Revenue Market Share by Application (2021–2026)

Table 67. Global Mesalazine Revenue Market Share by Application (2027–2032)

Table 68. Global Mesalazine Price (US$/kg) by Application (2021–2026)

Table 69. Global Mesalazine Price (US$/kg) by Application (2027–2032)

Table 70. PharmaZell Company Information

Table 71. PharmaZell Description and Business Overview

Table 72. PharmaZell Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 73. PharmaZell Mesalazine Product

Table 74. PharmaZell Recent Developments/Updates

Table 75. Syntese A/S Company Information

Table 76. Syntese A/S Description and Business Overview

Table 77. Syntese A/S Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 78. Syntese A/S Mesalazine Product

Table 79. Syntese A/S Recent Developments/Updates

Table 80. Cambrex Corporation Company Information

Table 81. Cambrex Corporation Description and Business Overview

Table 82. Cambrex Corporation Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 83. Cambrex Corporation Mesalazine Product

Table 84. Cambrex Corporation Recent Developments/Updates

Table 85. Divis Laboratories Company Information

Table 86. Divis Laboratories Description and Business Overview

Table 87. Divis Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 88. Divis Laboratories Mesalazine Product

Table 89. Divis Laboratories Recent Developments/Updates

Table 90. Chemi SpA Company Information

Table 91. Chemi SpA Description and Business Overview

Table 92. Chemi SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 93. Chemi SpA Mesalazine Product

Table 94. Chemi SpA Recent Developments/Updates

Table 95. Ipca Laboratories Company Information

Table 96. Ipca Laboratories Description and Business Overview

Table 97. Ipca Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 98. Ipca Laboratories Mesalazine Product

Table 99. Ipca Laboratories Recent Developments/Updates

Table 100. Hangzhou Brother Company Information

Table 101. Hangzhou Brother Description and Business Overview

Table 102. Hangzhou Brother Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 103. Hangzhou Brother Mesalazine Product

Table 104. Hangzhou Brother Recent Developments/Updates

Table 105. Lianyungang Fengheng Biopharm Company Information

Table 106. Lianyungang Fengheng Biopharm Description and Business Overview

Table 107. Lianyungang Fengheng Biopharm Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 108. Lianyungang Fengheng Biopharm Mesalazine Product

Table 109. Lianyungang Fengheng Biopharm Recent Developments/Updates

Table 110. Lasa Loboratory Company Information

Table 111. Lasa Loboratory Description and Business Overview

Table 112. Lasa Loboratory Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 113. Lasa Loboratory Mesalazine Product

Table 114. Lasa Loboratory Recent Developments/Updates

Table 115. Corden Pharma Bergamo Company Information

Table 116. Corden Pharma Bergamo Description and Business Overview

Table 117. Corden Pharma Bergamo Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 118. Corden Pharma Bergamo Mesalazine Product

Table 119. Corden Pharma Bergamo Recent Developments/Updates

Table 120. Erregierre SpA Company Information

Table 121. Erregierre SpA Description and Business Overview

Table 122. Erregierre SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 123. Erregierre SpA Mesalazine Product

Table 124. Erregierre SpA Recent Developments/Updates

Table 125. CTX Lifescience Company Information

Table 126. CTX Lifescience Description and Business Overview

Table 127. CTX Lifescience Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 128. CTX Lifescience Mesalazine Product

Table 129. CTX Lifescience Recent Developments/Updates

Table 130. Ishita Active Pharma Ingredients Company Information

Table 131. Ishita Active Pharma Ingredients Description and Business Overview

Table 132. Ishita Active Pharma Ingredients Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 133. Ishita Active Pharma Ingredients Mesalazine Product

Table 134. Ishita Active Pharma Ingredients Recent Developments/Updates

Table 135. YC Biotech (Jiangsu) Company Information

Table 136. YC Biotech (Jiangsu) Description and Business Overview

Table 137. YC Biotech (Jiangsu) Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 138. YC Biotech (Jiangsu) Mesalazine Product

Table 139. YC Biotech (Jiangsu) Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Mesalazine Distributors List

Table 143. Mesalazine Customers List

Table 144. Mesalazine Market Trends

Table 145. Mesalazine Market Drivers

Table 146. Mesalazine Market Challenges

Table 147. Mesalazine Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Mesalazine

Figure 2. Global Mesalazine Market Value by Purity (US$ Million), 2021–2032

Figure 3. Global Mesalazine Market Share by Purity: 2025 & 2032

Figure 4. Purity ≥ 97% Product Picture

Figure 5. Purity ≥ 98% Product Picture

Figure 6. Purity ≥ 99% Product Picture

Figure 7. Global Mesalazine Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Mesalazine Market Share by Application: 2025 & 2032

Figure 9. Tablets

Figure 10. Capsules

Figure 11. Granule

Figure 12. Suppository

Figure 13. Enema

Figure 14. Others

Figure 15. Global Mesalazine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Mesalazine Market Size (US$ Million), 2021–2032

Figure 17. Global Mesalazine Sales (Tons), 2021–2032

Figure 18. Global Mesalazine Average Price (US$/kg), 2021–2032

Figure 19. Mesalazine Report Years Considered

Figure 20. Mesalazine Sales Share by Manufacturers in 2025

Figure 21. Global Mesalazine Revenue Share by Manufacturers in 2025

Figure 22. Top 5 and Top 10 Global Mesalazine Players: Market Share by Revenue in Mesalazine in 2025

Figure 23. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 24. Global Mesalazine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 25. North America Mesalazine Sales Market Share by Country (2021–2032)

Figure 26. North America Mesalazine Revenue Market Share by Country (2021–2032)

Figure 27. U.S. Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. Canada Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Europe Mesalazine Sales Market Share by Country (2021–2032)

Figure 30. Europe Mesalazine Revenue Market Share by Country (2021–2032)

Figure 31. Germany Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. France Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. U.K. Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Italy Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Russia Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Asia Pacific Mesalazine Sales Market Share by Region (2021–2032)

Figure 37. Asia Pacific Mesalazine Revenue Market Share by Region (2021–2032)

Figure 38. China Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Japan Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. South Korea Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. India Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Australia Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Taiwan Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Indonesia Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Thailand Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Malaysia Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Philippines Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Latin America Mesalazine Sales Market Share by Country (2021–2032)

Figure 49. Latin America Mesalazine Revenue Market Share by Country (2021–2032)

Figure 50. Mexico Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Brazil Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Argentina Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Middle East and Africa Mesalazine Sales Market Share by Country (2021–2032)

Figure 54. Middle East and Africa Mesalazine Revenue Market Share by Country (2021–2032)

Figure 55. Turkey Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Saudi Arabia Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. UAE Mesalazine Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Global Sales Market Share of Mesalazine by Purity (2021–2032)

Figure 59. Global Revenue Market Share of Mesalazine by Purity (2021–2032)

Figure 60. Global Mesalazine Price (US$/kg) by Purity (2021–2032)

Figure 61. Global Sales Market Share of Mesalazine by Application (2021–2032)

Figure 62. Global Revenue Market Share of Mesalazine by Application (2021–2032)

Figure 63. Global Mesalazine Price (US$/kg) by Application (2021–2032)

Figure 64. Mesalazine Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oral Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalamine Market Research Report 2024

Global Mesalamine API Market Research Report 2024

Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalazine Suppositories Market Research Report 2024

5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Balsalazide Disodium Market Research Report 2025

Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030

Global Adalimumab Market Insights Forecast to 2030

Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024

Global Sodium 4 Aminosalicylate Market Research Report 2024

Vesanoid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalazine Enteric Coated Tablets Market Research Report 2024

Global Sulfadimidine and Sodium Salt Market Research Report 2024

Global Humira Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions